Dual Antagonism of α9α10 nAChR and GABA B Receptor-Coupled Ca V 2.2 Channels by an Analgesic αO-Conotoxin Analogue
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.3c00979 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Xiao Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, 5 Yushan Road, Qingdao 266…. Hauptthemen laut MEDLINE: Conotoxins, Analgesics, Non-Narcotic, Receptors, Nicotinic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Qingdao National Laboratory for Marine Science and Technology, Australian Research Council, National Natural Science Foundation of China.
Abstract (Originalsprache)
Pain severely affects the physical and mental health of patients. The need to develop nonopioid analgesic drugs to meet medical demands is urgent. In this study, we designed a truncated analogue of αO-conotoxin, named GeX-2, based on disulfide-bond deletion and sequence truncation. GeX-2 retained the potency of its parent peptide at the human α9α10 nAChR and exhibited potent inhibitory activity at CaV2.2 channels via activation of the GABAB receptor (GABABR). Importantly, GeX-2 significantly alleviated pain in the rat model of chronic constriction injury. The dual inhibition of GeX-2 at both α9α10 nAChRs and CaV2.2 channels is speculated to synergistically mediate the potent analgesic effects. Results from site-directed mutagenesis assay and computational modeling suggest that GeX-2 preferentially interacts with the α10(+)α10(-) binding site of α9α10 nAChR and favorably binds to the top region of the GABABR2 subunit. The study offers vital insights into the molecular action mechanism of GeX-2, demonstrating its potential as a novel nonopioid analgesic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, 5 Yushan Road, Qingdao 266003, China.
- Laboratory for Marine Drugs and Bioproducts, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266003, China.
- Illawarra Health and Medical Research Institute (IHMRI), Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South Wales 2522, Australia.
ORCID-Profile: Han-Shen Tae, Jinghui Zhang, Tao Jiang, David J Adams, Rilei Yu
Förderung
- Qingdao National Laboratory for Marine Science and Technology
- Australian Research Council
- National Natural Science Foundation of China
- Shandong Major Innovation Project
Zitieren
APA
Li, X., Tae, H. S., Chen, S., Yousuf, A., Huang, L., Zhang, J., Jiang, T., Adams, D. J., & Yu, R. (2024). Dual Antagonism of α9α10 nAChR and GABA B Receptor-Coupled Ca V 2.2 Channels by an Analgesic αO-Conotoxin Analogue. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c00979
Vancouver
Li X, Tae HS, Chen S, Yousuf A, Huang L, Zhang J, et al. Dual Antagonism of α9α10 nAChR and GABA B Receptor-Coupled Ca V 2.2 Channels by an Analgesic αO-Conotoxin Analogue. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.3c00979
BibTeX
@article{Li2024,
author = {Li, Xiao and Tae, Han-Shen and Chen, Shen and Yousuf, Arsalan and Huang, Linhong and Zhang, Jinghui and Jiang, Tao and Adams, David J and Yu, Rilei},
title = {Dual Antagonism of α9α10 nAChR and GABA B Receptor-Coupled Ca V 2.2 Channels by an Analgesic αO-Conotoxin Analogue},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.3c00979}
}
EUVIMED